SB 98

  • Virginia Senate Bill
  • 2024 Regular Session
  • Introduced in Senate Jan 02, 2024
  • Passed Senate Jan 26, 2024
  • Passed House Feb 23, 2024
  • Signed by Governor Apr 02, 2024

Health insurance; if prior authorization request is approved for prescription drugs.

Abstract

Health insurance; prior authorization. Requires that any provider contract between a carrier and a participating health care provider contain specific provisions that require that if a prior authorization request is approved for prescription drugs and such prescription drugs have been scheduled, provided, or delivered to the patient consistent with the authorization, the carrier shall not revoke, limit, condition, modify, or restrict that authorization unless (i) there is evidence that the authorization was obtained based on fraud or misrepresentation; (ii) final actions by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer remove the drug from the market, limit its use in a manner that affects the authorization, or communicate a patient safety issue that would affect the authorization alone or in combination with other authorizations; (iii) a combination of drugs prescribed would cause a drug interaction; or (iv) a generic or biosimilar is added to the prescription drug formulary. The bill provides that such provisions do not require a carrier to cover any benefit not otherwise covered or cover a prescription drug if the enrollee is no longer covered by a health plan on the date the prescription drug was scheduled, provided, or delivered. This bill is identical to HB 1134.

Health insurance; prior authorization. Requires that any provider contract between a carrier and a participating health care provider contain specific provisions that require that if a prior authorization request is approved and services and supplies have been scheduled, provided, or delivered to the patient consistent with the authorization, the carrier shall not revoke, limit, condition, modify, or restrict that authorization unless (i) there is evidence that the authorization was obtained based on fraud or misrepresentation; (ii) final actions by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer remove the drug from the market, limit its use in a manner that affects the authorization, or communicate a patient safety issue that would affect the authorization alone or in combination with other authorizations; (iii) a combination of drugs prescribed would cause a drug interaction; or (iv) a generic or biosimilar is added to the prescription drug formulary. The bill provides that such provisions do not require a carrier to cover any benefit not otherwise covered or cover a prescription drug if the enrollee is no longer covered by a health plan on the date the prescription drug was scheduled, provided, or delivered.

Health insurance; prior authorization. Requiresthat any provider contract between a carrier and a participatinghealth care provider contain specific provisions that prohibit thecarrier from revoking, limiting, conditioning, modifying, or restrictinga prior authorization if such prior authorization request has beenapproved and services, drugs, or supplies have been provided or deliveredto the patient consistent with such prior authorization unless thereis evidence that the request was approved based on fraud or misinformation.The bill also extends from 30 days to 90 days the period of a member'sprescription drug benefit coverage under a new health plan duringwhich a carrier is required to honor a prior authorization by anothercarrier.

Bill Sponsors (1)

Votes


Actions


Apr 02, 2024

Office of the Governor

Acts of Assembly Chapter text (CHAP0338)

Office of the Governor

Approved by Governor-Chapter 338 (effective 7/1/24)

Mar 11, 2024

Office of the Governor

Governor's Action Deadline 11:59 p.m., April 8, 2024

Senate

Enrolled Bill Communicated to Governor on March 11, 2024

Mar 08, 2024

Senate

Impact statement from SCC (SB98ER)

Mar 07, 2024

Senate

Signed by President

Mar 04, 2024

Senate

Enrolled

House

Signed by Speaker

Senate

Bill text as passed Senate and House (SB98ER)

Feb 27, 2024

Senate

House amendment agreed to by Senate (39-Y 0-N)

Feb 23, 2024

House

Read third time

House

VOTE: Block Vote Passage (98-Y 0-N)

House

Passed House with amendment BLOCK VOTE (98-Y 0-N)

House

Engrossed by House as amended

House

Committee amendment agreed to

Feb 22, 2024

House

Read second time

Feb 20, 2024

House

Reported from Labor and Commerce with amendment(s) (22-Y 0-N)

Feb 13, 2024

House

Referred to Committee on Labor and Commerce

House

Read first time

House

Placed on Calendar

Jan 29, 2024

Senate

Impact statement from SCC (SB98S1)

Jan 26, 2024

Senate

Read third time and passed Senate (38-Y 0-N)

Jan 25, 2024

Senate

Reading of substitute waived

Senate

Engrossed by Senate - committee substitute SB98S1

Senate

Committee substitute agreed to 24105929D-S1

Senate

Read second time

Jan 24, 2024

Senate

Constitutional reading dispensed (40-Y 0-N)

Senate

Impact statement from SCC (SB98)

Jan 22, 2024

Senate

Reported from Commerce and Labor with substitute (15-Y 0-N)

Senate

Committee substitute printed 24105929D-S1

Senate

Senate committee, floor amendments and substitutes offered

Jan 02, 2024

Senate

Referred to Committee on Commerce and Labor

Senate

Prefiled and ordered printed; offered 01/10/24 24101001D

Bill Text

Bill Text Versions Format
Prefiled and ordered printed; offered 01/10/24 24101001D PDF HTML
Committee substitute printed 24105929D-S1 PDF HTML
SB98ER PDF HTML
CHAP0338 PDF HTML

Related Documents

Document Format
Fiscal Impact Statement: SB98FER171.PDF PDF
Fiscal Impact Statement: SB98FS1171.PDF PDF
Fiscal Impact Statement: SB98F171.PDF PDF
Amendment: SB98AHE HTML
Amendment: SB98AH HTML

Sources

Data on Open States is updated periodically throughout the day from the official website of the Virginia General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.